help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Branham, W. S.
Right arrow Articles by Ridlon, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Branham, W. S.
Right arrow Articles by Ridlon, E.

Endocrinology, Vol 117, 2238-2248, Copyright © 1985 by Endocrine Society


ARTICLES

Inhibition of rat uterine gland genesis by tamoxifen

WS Branham, DM Sheehan, DR Zehr, KL Medlock, CJ Nelson and E Ridlon

We have previously shown that rat uterine gland genesis occurs rapidly and synchronously between postnatal days 9-15. Exogenous estrogens either stimulate or inhibit gland genesis depending on dose and age at administration. We therefore examined the developmental effects of the triphenylethylene antiestrogen tamoxifen, which exhibits both estrogen agonist and antagonist properties, in the postnatal rat uterus. Tamoxifen administered sc in oil on postnatal days 1-5 or days 10-14 caused dose-related inhibition of uterine gland genesis which persisted to day 26 or day 60, respectively. Tamoxifen administered on postnatal days 20-24, which is after the age of normal gland genesis, did not alter the number of preexisting glands. A 24-h exposure to tamoxifen inhibited 17 beta-estradiol (E2)-induced ornithine decarboxylase (ODC) activity measured 6 h after E2 administration in 14-day-old rats. Treatment with tamoxifen before or during the period of gland genesis also reduced uterine responsiveness to a single dose of E2 as measured by both uterine weight gain (after a 24-h exposure on days 14, 19, 22, and 26) and the pattern of E2-induced ODC activity in 26-day-old rats. Control rats respond to E2 with peaks of ODC activity at 6 and 18 h after administration. Treatment with tamoxifen on either postnatal days 1-5 or 10-14 reduced the 18-h peak to approximately half of controls but did not affect the 6-h E2-induced ODC peak. Analysis of both nuclear and translocatable cytosol estrogen receptor in uteri from 26- day-old rats indicate that neither the dissociation constant (KD) nor the number of binding sites was affected by tamoxifen treatment on postnatal days 1-5 or 10-14.


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
K. Hayashi and T. E. Spencer
WNT Pathways in the Neonatal Ovine Uterus: Potential Specification of Endometrial Gland Morphogenesis by SFRP2
Biol Reprod, April 1, 2006; 74(4): 721 - 733.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A Makker, F W Bansode, V M L Srivastava, and M M Singh
Antioxidant defense system during endometrial receptivity in the guinea pig: effect of ormeloxifene, a selective estrogen receptor modulator
J. Endocrinol., January 1, 2006; 188(1): 121 - 134.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Hayashi and T. E. Spencer
Estrogen Disruption of Neonatal Ovine Uterine Development: Effects on Gene Expression Assessed by Suppression Subtraction Hybridization
Biol Reprod, October 1, 2005; 73(4): 752 - 760.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Hayashi, K. D. Carpenter, and T. E. Spencer
Neonatal Estrogen Exposure Disrupts Uterine Development in the Postnatal Sheep
Endocrinology, July 1, 2004; 145(7): 3247 - 3257.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Mericskay, J. Kitajewski, and D. Sassoon
Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus
Development, May 1, 2004; 131(9): 2061 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. D. Carpenter, C. A. Gray, T. M. Bryan, T. H. Welsh Jr., and T. E. Spencer
Estrogen and Antiestrogen Effects on Neonatal Ovine Uterine Development
Biol Reprod, August 1, 2003; 69(2): 708 - 717.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Yoshida, S.-i. Katsuda, T. Tanimoto, S. Asai, D. Nakae, Y. Kurokawa, K. Taya, and A. Maekawa
Induction of different types of uterine adenocarcinomas in Donryu rats due to neonatal exposure to high-dose p-t-octylphenol for different periods
Carcinogenesis, October 1, 2002; 23(10): 1745 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. Yoshida, A. Takenaka, S.-I. Katsuda, Y. Kurokawa, and A. Maekawa
Neonatal Exposure to p-tert-octylphenol Causes Abnormal Expression of Estrogen Receptor {alpha} and Subsequent Alteration of Cell Proliferating Activity in the Developing Donryu Rat Uterus
Toxicol Pathol, April 1, 2002; 30(3): 357 - 364.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
C. A. Gray, F. F. Bartol, B. J. Tarleton, A. A. Wiley, G. A. Johnson, F. W. Bazer, and T. E. Spencer
Developmental Biology of Uterine Glands
Biol Reprod, November 1, 2001; 65(5): 1311 - 1323.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. M. Taylor, C. A. Gray, M. M. Joyce, M. D. Stewart, F. W. Bazer, and T. E. Spencer
Neonatal Ovine Uterine Development Involves Alterations in Expression of Receptors for Estrogen, Progesterone, and Prolactin
Biol Reprod, April 1, 2000; 63(4): 1192 - 1204.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society